[Form 4] Vital Energy, Inc. Insider Trading Activity
Rhea-AI Filing Summary
A Vital Energy director reported cash settlement of 18,814 deferred stock units in connection with the closing of the company’s merger with Crescent Energy. On December 15, 2025, 18,814 deferred stock units converted into the same number of shares of Vital Energy common stock, and 20,561 shares of common stock were then disposed of, leaving the director with no remaining Vital common shares or related units.
Under the merger agreement dated August 24, 2025, the Vital Energy and Crescent Energy transaction closed on December 15, 2025 through a two-step merger structure that made Vital a wholly owned subsidiary of Crescent. The reporting person’s deferred stock account became payable in a lump-sum cash amount based on the number of shares in the account and the $17.92 closing price of Vital common stock on December 12, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Deferred Stock Units | 18,814 | $0.00 | -- |
| Exercise | Common Stock | 18,814 | $0.00 | -- |
| Disposition | Common Stock | 20,561 | $0.00 | -- |
Footnotes (1)
- On December 15, 2025 (the "Closing Date"), the transactions contemplated by the Agreement and Plan of Merger, dated August 24, 2025, (the "Merger Agreement"), by and among Crescent Energy Company, a Delaware corporation ("Crescent"), Venus Merger Sub I Inc., a Delaware corporation and a wholly owned subsidiary of Crescent ("Merger Sub Inc."), Venus Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of Crescent ("Merger Sub LLC"), and Vital Energy, Inc. (the "Issuer") were consummated. Pursuant to the Merger Agreement, (i) Merger Sub Inc. merged with and into the Issuer (the "First Company Merger"), with the Issuer continuing as the surviving entity (the "Surviving Corporation") and (ii) immediately following the First Company Merger, the Surviving Corporation merged with and into Merger Sub LLC, with Merger Sub LLC continuing as the surviving entity and a wholly owned subsidiary of Crescent. Pursuant to the Merger Agreement, the amounts in the Reporting Person's "Deferred Stock Account" (as such term is defined under the Issuer's Director Deferred Compensation Plan) (each, a "Vital Director Deferred Stock Award") became payable in a lump sum cash payment equal to (i) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Vital Common Stock"), subject to such Vital Director Deferred Stock Award and (ii) $17.92, the closing price of one share of Vital Common Stock on December 12, 2025 (the trading date immediately preceding the Closing Date).
